Major reduction in AIDS-mortality inequalities after HAART: The importance of absolute differences in evaluating interventions

Social Science and Medicine

Volumn 68, Issue 3, 2009, Pages 419-426

  Regidor, Enrique ^a,b   Sánchez, Elisabeth ^c,d   de la Fuente, Luis ^b,c,e   Luquero, Francisco J ^c,f   de Mateo, Salvador ^b,c   Domínguez, Vicente ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c CARLOS III INSTITUTE OF HEALTH   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e Plan Nacional sobre Sida   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Absolute differences; AIDS; HAART; Measures of inequities in health; Neighbourhoods; Relative differences; Spain

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CENSUS; COHORT ANALYSIS; MORTALITY; NEIGHBORHOOD; SOCIOECONOMIC CONDITIONS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; POVERTY; REGISTRIES; RESIDENCE CHARACTERISTICS; SOCIAL CLASS; SPAIN; SURVIVAL ANALYSIS; URBAN HEALTH; VULNERABLE POPULATIONS; YOUNG ADULT;

EURASIA; EUROPE; MADRID [SPAIN]; SOUTHERN EUROPE; SPAIN;

EID: 58749088527     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2008.10.039     Document Type: Article

References (48)

1. Antunes J.L.F., Waldman E.A., and Borrel l.C. Is it possible to reduce AIDS deaths without reinforcing socioeconomic inequalities in health?. International Journal of Epidemiology 34 (2005) 586-592
2. Blakely T. The New Zealand census-mortality study: Socioeconomic inequalities and adult mortality, 1991-1994 (2002), Ministry of Health, Wellington
3. Borrell C., Regidor E., Arias L.C., Navarro P., Ruigpinós R., Domínguez V., et al. Inequalities in mortality according to educational level in two large Southern European cities. International Journal of Epidemiology 28 (1999) 58-63
4. Borrell C., Rodríguez-Sanz M., Pasarín M.I., Brugal M.T., García de Olalla P., Marí-Dell Olmo M., et al. AIDS mortality before and alter the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?. European Journal of Public Health 16 (2006) 601-608
5. Cano-Serral G., Perez G., Borrell C., and COMPARA Group. Comparability between ICD-9 and ICD-10 for the leading causes of death in Spain. Revue d'Epidémilogie et de Santé Publique 54 (2006) 355-365
6. Castilla J., Lorenzo J.M., Izquierdo A., Lezaun M.E., López I., Moreno-Iribas C., et al. Characteristics and trends of newly diagnosed HIV-infections, 2000-2004. Gaceta Sanitaria 20 (2006) 442-448
7. Castilla J., del Romero J., Hernando V., Marincovich B., García S., and Rodríguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. Journal of Acquired Immune Deficiency Syndromes 40 (2005) 96-101
8. Clayton D., and Hills M. Statistical models in epidemiology (1993), Oxford University Press, Oxford 249-260
9. Crocetti E., Giovannetti L., Borrel,l C., Pasarin M.I., Cirera E., and Plasencia A. Decreasing AIDS mortality rates among young adults in the city of Florence, 1987-1999. Journal of Epidemiology and Community Health 56 (2002) 399-400
10. De la Fuente L., Bravo M.J., Toro C., Brugal M.T., Barrio G., Soriano V., et al. Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes. Journal of Epidemiology and Community Health 60 (2006) 537-542
11. De la Fuente L., Brugal M.T., Ballesta R., Bravo M.J., Barrio G., Domingo A., et al. Metodología del estudio de cohortes del proyecto Itinere sobre consumidores de heroína en tres ciudades españolas y características básicas de los participantes. Revista Española de Salud Pública 79 (2005) 475-491
12. Delegación del Gobierno para el Plan Nacional sobre Drogas (DGPNSD). Observatorio Español sobre Drogas. Informe 2004 (2005), Ministerio de Sanidad y Consumo, Madrid
13. Dray-Spira R., and Lert F. Social inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy. AIDS 17 (2003) 283-290
14. Goldman D.P., and Smith J.P. Can patient self-management help explain the SES gradient?. Proceedings of the National Academy of Sciences 99 (2002) 10929-10934
15. Grrigg B., Brooks R.C., Lieb S., and Grigg M. Coding changes and apparent HIV/AIDS mortality trends in Florida, 1999. Journal of the American Medical Association 286 (2001) 1839
16. Harper S., and Lynch J. Measuring health inequalities. In: Oakes J.M., and Kaufman J.S. (Eds). Methods in social epidemiology (2006), Jossey-Bass, San Francisco 134-168
17. Harper S., and Lynch J. Highly active antiretroviral therapy and socioeconomic inequalities in AIDS mortality in Spain. European Journal of Public Health 17 (2007) 231
18. Harper S., Lynch J., Meersman S.C., Breen N., Davis W.W., and Reichman M.E. Respond to "Measuring social disparities in health". American Journal of Epidemiology 167 (2008) 905-907
19. Huisman M., Kunst E., Bopp M., Borgan J.K., Borrel,l C., Costa G., et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet 365 (2005) 493-500
20. Jarrin I., Lumbreras B., Ferreros I., Pérez-Hoyos S., Hurtado I., and Hernández-Aguado I. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART. International Journal of Epidemiology 36 (2007) 187-194
21. Karon J.M., Fleming P.L., Steketee R.W., and De Cock K.M. HIV in the United States at the turn of the century: an epidemic in transition. American Journal of Public Health 91 (2001) 1060-1068
22. Katz M.H., Hsu L., Lingo M., Wolffer G., and Schwarcz S.K. Impact of socioeconomic status on survival with AIDS. American Journal of Epidemiology 148 (1998) 282-291
23. Leite M.L., Nicolosi A., Osella A.L., Molinari S., Cozzolino E., Velati C., et al. Modeling incidence rate ratio and rate difference: additivity or multiplicativity of human immunodeficiency virus parenteral and sexual transmission among intravenous drug users. American Journal of Epidemiology 141 (1995) 16-24
24. Lewden C., Raffi F., Cuzin L., Cailleton V., Vilde J.L., Chene G., et al. Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiproteases Cohort Agence Nationale de Recherches sur le SIDA EP 11 study. Journal of Infectious Diseases 186 (2002) 710-714
25. López-Gay D., Izarra C., Cevallos C., and Vera I. Vigilancia de la infección por VIH/Sida en la Comunidad de Madrid. Situación a 31 de diciembre de 2005. Boletín Epidemiológico de la Comunidad de Madrid 12 (2006) 3-55
26. Mackenbach J.P., Cavelaars A.E.J.M., and Kunst A.E. Socioeconomic inequalities in morbidity and mortality in western Europe. Lancet 350 (1997) 517
27. Mackenbach J.P., and Kunst A.E. Measuring the magnitude of socio-economic inequalities in health: an overview of available measures illustrated with two examples from Europe. Social Science & Medicine 44 (1997) 757-771
28. Mannheimer S.B., Curtis J.L., and EL-Sadr W.M. Use of antiretroviral therapy by intravenous drug users with HIV. Journal of the American Medical Association 281 (1999) 699-701
29. Marí-Dell'Olmo M., Rodríguez-Sanz M., García de Olalla P., Pasarín M.I., Brugal M.T., Caylà J., et al. Individual and community-level effects in the socioeconomic inequalities of AIDS-related mortality in an urban area of southern Europe. Journal of Epidemiology and Community Health 61 (2007) 232-240
30. Martikainen P.T., and Valkonen P.T. Excess mortality of unemployed men and women during a period of rapidly increasing unemployment. Lancet 348 (1996) 909-912
31. McFarland W., Chen S., Hsu L., Schwarcz S., and Katz M. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. Journal of Acquired Immune Deficiency Syndromes 33 (2003) 96-103
32. Messer L.C. Measuring social disparity in health - what was the question again?. American Journal of Epidemiology 167 (2008) 900-904
33. Ministerio de Sanidad y Consumo. Recomendaciones del Consejo Asesor Clínico del Plan Nacional sobre Sida 10 (2001), Ministerio de Sanidad y Consumo, Madrid 1-16
34. Oliver A., Healey A., and Le Grand J. Addressing health inequalities. The Lancet 360 (2002) 565-567
35. Palella F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., et al., Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. The New England Journal of Medicine 338 (1998) 853-860
36. Porco T.C., Martin J.N., Page-Shafer K.A., Cheng A., Charlebois E., Grant R.M., et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 18 (2004) 81-88
37. Rapiti E., Porta D., Forastiere F., Fusco D., and Perucci C.A. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy. Epidemiology 11 (2000) 496-501
38. Regidor E. Measures of health inequalities: part 2. Journal of Epidemiology and Community Health 58 (2004) 900-903
39. Regidor E., De la Fuente L., Calle M.E., Navarro P., and Domínguez V. Unusually strong association between education and mortality in young adults in a community with a high rate of injection-drug users. European Journal of Public Health 13 (2003) 334-339
40. SAS Institute Inc. SAS system for windows V8 (1999), SAS Institute Inc, Cary, NC
41. Smit C., Geskus R., Uitebroek D., Mulder D., van Deen Hoek S., Coutinho R.A., et al. Declining AIDS mortality in Amsterdam. Contributions of declining HIV incidence and effective therapy. Epidemiology 15 (2004) 536-542
42. Strand B.H., Kunst A., Huisman M., Menvielle G., Glickman M., Bopp M., et al. The reversed social gradient: higher breast cancer mortality in the higher educated compared to lower educated. A comparison of 11 European populations during the 1990s. European Journal of Cancer 43 (2007) 1200-1207
43. Strathdee S.A., Paleu A., Cornelisse P.G., Yip B., O'Shaughnessy M.V., Monstaner J.S., et al. Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association 280 (1998) 547-549
44. The R Project of Statistical Computing (2007). www.r-project.org Accessed April 2007
45. Vagero D., and Erikson R. Socioeconomic inequalities in morbidity and mortality in western Europe. Lancet 350 (1997) 516
46. Victora C.G., Vaughan J.P., Barros G.C., Sliva A.C., and Tomasi E. Explaining trends in inequities: evidence from Brazilian child health studies. The Lancet 356 (2000) 1093-1098
47. Wacholder S. Binomial regression in GLIM: estimating risk ratio and risk differences. American Journal of Epidemiology 123 (1986) 174-184
48. Wood E., Montaner J.S.G., Chan K., Tyndall M.W., Schecther M.T., Bangsberg D., et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS 16 (2002) 2065-2072